CODIS
LIVE

Serial Number

99496902

Owner

Particle Dynamics Holdings, Inc

Attorney

Joel R. Samuels

Filing Date

Nov 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CODIS Trademark

Serial Number: 99496902

CODIS is a trademark filed by Particle Dynamics Holdings, Inc on November 14, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Particle Dynamics Holdings, Inc

2629 South Hanley Road
St. Louis, MO 63144

Entity Type: 03

Trademark Details

Filing Date

November 14, 2025

Registration Date

Not Registered

Published for Opposition

July 21, 2026

Goods & Services

Pharmaceutical research and development; contract development services for pharmaceuticals; Pharmaceutical research and development in the nature of pharmaceutical product design and optimization; Pharmaceutical research and development in the nature of analytical testing of pharmaceuticals; Pharmaceutical research and development in the nature of stability testing; Pharmaceutical research and development in the nature of method development and validation; Pharmaceutical research and development in the nature of technology transfer in the field of pharmaceuticals; consulting services in the field of drug development and manufacturing

Contract pharmaceutical manufacturing services in the field of pharmaceuticals; custom synthesis of active pharmaceutical ingredients (APIs); formulation of pharmaceutical preparations for others; Contract pharmaceutical manufacturing services in the nature of pharmaceutical spray drying services; Contract pharmaceutical manufacturing services in the nature of solvent spray drying services; Contract pharmaceutical manufacturing services in the nature of pharmaceutical tableting, encapsulation, and blending services; Contract pharmaceutical manufacturing services in the nature of packaging services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of labeling services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of processing of pharmaceutical intermediates; scale-up and commercial manufacturing of pharmaceutical products for others; consulting services in the field of manufacturing

Dietary and nutritional supplements; active pharmaceutical ingredients (APIs), namely, Sevelamer Carbonate and Sevelamer Hydrochloride; drug delivery systems in the form of amorphous solid dispersions that facilitate the delivery of pharmaceutical preparations; spray-dried pharmaceutical products for treatment of hyperphosphatemia

Magnesium carbonate; Particulate precursor components in the nature of chemical additives for use in the manufacture of pharmaceutical tablets and nutritional and dietary supplements; chemicals sold in bulk for use in the manufacturing, processing and packing of nutritional supplements, vitamins, and pharmaceutical products and preparations; chemical encased in a matrix which is sold in bulk for manufacturing, processing or repacking of chemicals; Chemical tastemasking additives, stability and flavor enhancers, for use in the manufacture of pharmaceuticals, namely, antihistamines, anti-nausea agents, neonatal agents, osteoporetic, nutraceuticals, and pharmaceuticals, namely, hormones, anti-infectives, and fertility agents; Excipients for use in the manufacture of pharmaceuticals

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 14, 2025 MAFR
NEW APPLICATION ENTERED
Nov 14, 2025 NWAP